Irinotecan in Treating Patients With Metastatic Colorectal Cancer
NCT00003544
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
OTHER
Sponsor class
Conditions
Colorectal Cancer
Interventions
DRUG:
irinotecan hydrochloride
PROCEDURE:
surgical procedure
Sponsor
Memorial Sloan Kettering Cancer Center
Collaborators
[object Object]